Method of controlling pharmacokinetics of immunomodulatory compounds
OwnerRonald J. Pettisinventor
Life of this patent
Estimating the term…
Abstract
A method and device for administration of an immunomodulatory substance into skin.
Claims91
A method for directly delivering an immunomodulatory substance into an intradermal space within mammalian skin comprising administering the substance through at least one hollow needle having an outlet with an exposed height between 0 and 1 mm, said outlet being inserted into the skin to a depth of between 0.3 mm and 2 mm, such that delivery of the substance occurs at a depth between 0.3 mm and 2 mm.
A method of administering an immunomodulatory substance comprising injecting or infusing the substance intradermally through one or more microneedles having a length and outlet suitable for selectively delivering the substance into the dermis to obtain absorption of the substance in the dermis.
The method of claim 38 wherein said substance is a lipopolysacharride or BCG, or a synthetic derivative thereof.
A method for delivering an immunomodulatory substance to a subject comprising:
- contacting the skin of the subject with a device having a dermal-access means for accurately targeting the dermal space of the subject with an efficacious amount of the bioactive substance.
A method for delivering an immunomodulatory substance into tissue comprising delivering the substance within or beneath the skin at least into the intradermal space to access one or more compartments, which compartments afford the substance different pharmacokinetics, which enhance the effectiveness of the substance in terms of a resultant composite pharmacokinetics.
The method of claim 65 wherein the outlet is at a depth of about 750 μm to about 1.5 mm when the needle is inserted.
Dependencies are inferred from the claim text.